semaglutide aha 2023 | SELECT Trial: in Patients Without Diabetes Two-year effects of semaglutide in
Description
The transcriptional impacts caused by GLP-1 have shown to be cardioprotective due to their ability to lessen the formation of atheroma plaque
Understanding what to expectand how to manage the transitionhelps create a smoother path forward
The main incretins are GLP-1 and gastric inhibitory polypeptide (GIP)
Doctors are prescribing them much earlier in the individual journey, displacing older medications
The relationship between semaglutide and menstrual cycles involves complex hormonal interactions
They also promise to reduce the overall number of therapies requiring PA (one pledge is to cut a third of PA requirements by 2026) ( [42] ) ( [63] )
